An Indian climber and another from the Philippines became the first mountaineers to die on Mount Everest in the current March-May climbing season of the world's highest peak, hiking officials said on Friday.
Subrata Ghosh, 45, from India, died on Thursday below the Hillary Step while returning after reaching the 29,032 feet peak.
"He refused to descend from below the Hillary Step," said Bodhraj Bhandari of Nepal's Snowy Horizon Treks and Expedition organising company.
No other details were available.
The Hillary Step is located in the 'death zone', an area between 26,250 ft high South Col and the summit where the level of natural oxygen is inadequate for survival.
"Efforts are underway to bring his body down to the base camp. The cause of his death will be known only after post mortem," Bhandari said.
Philipp II Santiago, 45, from the Philippines, died late on Wednesday at the South Col while he was on his way up, said Himal Gautam, a tourism department official.
Santiago was tired when he reached the fourth high camp and died while resting in his tent, Gautam added.
Santiago and Ghose were both members of an international expedition organised by Bhandari.
Nepal has issued 459 permits to climb Everest during the current season that ends in May. Nearly 100 climbers and their guides have already reached the summit this week.
Mountain climbing, trekking and tourism is a source of income and employment for Nepal, one of the poorest countries in the world.
At least 345 people have died on Everest in more than 100 years since summiting expeditions were known to have started, according to the Himalayan data base and hiking officials.

St. Petersburg region port, oil terminal hit in Ukrainian drone attack
Trump extols America, rails at communism in US 250th celebration
Zelenskyy denies Russian capture of key eastern city Kostiantynivka
Keiko Fujimori declared winner of Peru presidential race
Ukrainian rescuers clear rubble as Kyiv mourns 30 killed in Russian attack
Monaco blast suspect is a Ukrainian woman who fled to Germany
Clinical trials begin for two potential Ebola treatments
India issues notice to Telegram, Signal on concerns over usernames, source says
